Getinge (OTCMKTS:GNGBY) Reaches New 1-Year High – Time to Buy?

Getinge (OTCMKTS:GNGBY) hit a new 52-week high during trading on Wednesday . The stock traded as high as $25.22 and last traded at $25.16, with a volume of 4601 shares traded. The stock had previously closed at $25.05.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Getinge from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Strong Buy”.

Getinge Price Performance

The company has a current ratio of 1.31, a quick ratio of 0.74 and a debt-to-equity ratio of 0.26. The stock has a market capitalization of $6.85 billion, a PE ratio of 23.96 and a beta of 0.92. The business has a fifty day moving average price of $21.52 and a 200-day moving average price of $21.35.

Getinge (OTCMKTS:GNGBY) last released its earnings results on Friday, July 17th. The company reported $0.38 earnings per share for the quarter. Getinge had a return on equity of 11.12% and a net margin of 7.81%.The company had revenue of $894.87 million during the quarter. Research analysts expect that Getinge will post 1.38 EPS for the current fiscal year.

About Getinge

Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.

The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.